Institutional members access full text with Ovid®

Share this article on:

The Microbiology of Postobstructive Pneumonia in Lung Cancer Patients

Hsu-Kim, Cynthia MD*; Hoag, Jeffrey B. MD, MS*,†; Cheng, Guang-Shin MD*; Lund, Mark E. MD*,†

Journal of Bronchology & Interventional Pulmonology: July 2013 - Volume 20 - Issue 3 - p 266–270
doi: 10.1097/LBR.0b013e31829ddf01
Review Article

Recurrent pneumonias often occur in the setting of an airway obstruction and can be the presenting symptom of an undiagnosed malignancy. Little is known regarding the microbiology of these pneumonias making antibiotic therapy difficult to direct; however, the few studies available show these pneumonias to be polymicrobial. Examining the colonization patterns of at-risk populations such as patients with chronic obstructive pulmonary disease and using techniques such as ultrasound and computed tomography-guided biopsies may help in the treatment of these pneumonias. The following review is presented to highlight the current medical knowledge as well as suggest areas for future evaluation.

*Drexel University College of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine

Advanced Center for Lung and Thoracic Oncology, Eastern Regional Medical Center, Cancer Treatment Centers of America, Philadelphia, PA

Disclosure: There is no conflict of interest or other disclosures.

Reprints: Mark E. Lund, MD, Advanced Center for Lung and Thoracic Oncology, Eastern Regional Medical Center, Cancer Treatment Centers of America, 1331 East Wyoming Avenue, MOB Suite 3170, Philadelphia, PA 19124 (e-mail: mark.lund@ctca-hope.com).

Received March 21, 2013

Accepted May 16, 2013

© 2013 by Lippincott Williams & Wilkins.